Medicus Pharma Ltd. (MDCX) Form 424B3 — Oct 16, 2026
Medicus Pharma Ltd. effected a 1-for-50 reverse share consolidation, which became effective October 12, 2026, with shares trading on a post-consolidation basis on Nasdaq the same day. Shareholders approved the consolidation at the June 3, 2026 meeting with board discretion up to 1-for-50, and the board unanimously approved the maximum ratio on September 24, 2026.
Key figures
- Warrant price
- 0.2
- Effective date
- 2026-10-12
- Warrant expiration
- 2029-11-15
- Reverse split ratio
- 1:50
- Share price post split
- 3.43
- Warrant exercise price
- 4.64
- Warrant shares registered
- 64911
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.